Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Between 42 and 55 days of age at the time of enrollment.~* Healthy infant free of chronic or serious medical condition as determined by history and physical examination at the time of study enrollment.~* Parents/guardians of each subject are able to understand and follow study procedures and agree to participate in the study by providing parental/guardian permission.~Exclusion Criteria:~* If child has previously had intussusception or abdominal surgery.~* Use of any immunosuppressive drugs or immunoglobulin and/or blood product use since birth or anticipated during study period.~* Current enrollment in any other intervention trial or use of any investigational drug or vaccine throughout the study period.~* Birthweight less than 2000 grams or gestation \< 36 weeks, if this information is available.~* Any subject who reports plan to leave the study area before the completion of the study (i.e., relocation, migration, etc.).~* Another child living in the same compound is already enrolled in the trial (i.e., only one participant can be enrolled per compound).~* After the rotavirus vaccine is introduced into the routine EPI system in Navrongo: Another child in the compound is less than 16 weeks of age.~* The child has received rotavirus vaccine outside of this study.

- Gender: ALL
- Minimum Age: 42 Days
- Maximum Age: 55 Days
- Healthy Volunteers: t

Study Arms:
- Rotavirus Vaccine at age 6 & 10 weeks (Type: ACTIVE_COMPARATOR): Participants are provided with the Human Rotavirus Vaccine (HRV) at 6 \& 10 weeks of age.
- Rotavirus vaccine at age 10 & 14 weeks (Type: EXPERIMENTAL): Participants are provided with the Human Rotavirus Vaccine (HRV) at 10 \& 14 weeks of age.
- Rotavirus vaccine at age 6,10,&14 weeks (Type: EXPERIMENTAL): Participants are provided with the Human Rotavirus Vaccine (HRV) at 6, 10, \& 14 weeks of age.

Based on this trial design, predict the completion outcome and termination type (if applicable).